** Shares of Krishna Institute of Medical Sciences KRII.NS
rise about 6% to 580 rupees apiece
** Stock rises after HSBC initiates "buy" on the hospital
chains operator, seeing an upside of 25.3% over the next 12
months
** HSBC says earnings likely to double over fiscal year
2024-2027
** Says KRII's well-defined capex with plans to add 2,385
beds over FY 2025-2027, improving case mix of lucrative
specialities such as mothercare/childcare and oncology to
sustain earnings growth
** While ambitious capex plan to expand bed capacity raises
some margin concerns, HSBC remains positive on KRII's execution
record
** Also says valuations of KRII remain attractive to peers
such as Apollo Hospital APLH.NS , Max Healthcare, a subsidiary
of Max Financial Services MAXI.NS , and Global Health GLOH.NS
** KRII shares up 40% in 2024 so far
** In September quarter alone, KRII is up 33.1%, on course
for best quarterly gains since listing in mid 2021 - Exchange
data
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))